Science Market Update

University of California, Los Angeles Virtual BioResearch Product Faire™ Event Oct 8, 2020

Posted by BCI Staff on Fri, Oct 02, 2020

University of California, Los Angeles

BioResearch Product Faire™

 

Virtual Event: Thursday, October 8, 2020

Attendance is free for science professionals.

Read More

Tags: University of California Los Angeles, Los Angeles, UCLA, 2020

UCLA: Meet Nearly 500 Top Researchers this Fall

Posted by BCI Staff on Wed, Aug 28, 2019

With 290 medical research centers and distinctive institutes, the University of California, Los Angeles is a powerhouse research university employing some of the leading life science researchers in the world. With a powerful global reputation, the University of California, Los Angeles offers a promising marketplace for lab suppliers working to market their biotech solutions and increase lab sales.

UCLA: Meet Nearly 500 Top Researchers this Fall

800px-boelter_hall,_ucla

 

Perhaps you are a lab supplier with a long history of doing business with UCLA life science researchers, or maybe you are brand new to the market. Regardless of your time investment, increasing lab sales at the University of California, Los Angeles is as easy as taking advantage of Biotechnology Calendar, Inc.’s well-established connections at the university and exhibiting at the upcoming UCLA event. Why should you focus on this marketplace? Consider these most recent funding statistics for the University of California, Los Angeles:

  • 2017 Total R&D Expenditures: $1,076,917,000
  • 2017 Life Science R&D Expenditures: $761,824,000

  • 2017 Total R&D ranking: 12th
  • 2018 NIH Funding: $408,733,609
  • A $50 million philanthropic gift was awarded to the University of California, Los Angeles to support the five-year, $4.2 billion, fund raising Centennial Campaign.
  • UCLA's AIDS Malignancy Consortium, led by professor of medicine Ronald Mitsuyasu, received nearly $24 million in NIH funding in 2018 and over $136 million since 2006.

  • UCLA's AIDS Clinical Trials Group, led by professor of medicine Judith Currier, received $24.5 million in NIH funding in 2018 and over $483 million since 2006.

Read More

Tags: CA, University of California Los Angeles, California, funding resource, Los Angeles, LAVS

USC Researchers Use Proteins to Boost Immune System in Fighting HIV

Posted by Laura Braden on Mon, Oct 02, 2017

HIV Infected H9 T-CellAccording to the World Health Organization, more than 36.7 million people around the world are infected with Human Immunodeficiency Virus (HIV). Although there is not yet a cure for HIV, some treatments are able to slow the spread of the virus. Researchers around the world study the virus with the hope of one day creating a cure to attack the virus. A team of researchers from the University of Southern California in Los Angeles are taking a different approach to fighting HIV - by creating a treatment that boosts the immune system instead of attacking the virus.

Read More

Tags: CA, University of Southern California, USC, Los Angeles, BioResearch Product Faire Event, HIV research, 2018, HIV treatment

UCLA Researchers: New Evidence for Novel Method of Cancer Metastasis

Posted by Greg Paul on Fri, Aug 26, 2016

Researchers from UCLA and partnering schools guided by Laurent Bentolila found evidence supporting the spread of malignant cells through angiotropism with vascular co-option, and even suggested they may be related or identical processes.  These findings were published in Nature Scientific Reports. With angiotropism being the ability for cells to travel along surface of blood vessels, but not be inside of them, also called extravascular migratory metastasis (EVMM) and vascular co-option being the ability for a tumor to use a blood supply and travel along it, this means cancer has an outlet to spread outside of the bloodstream.  The spread outside of the bloodstream means some current methods of treating cancer would be ineffective.

“... if the metastasizing cells are on the outside of the blood vessels, they escape exposure to the treatment and continue to spread cancer.”

-Laurent A. Bentolila

Read More

Tags: CA, University of California Los Angeles, cancer research, Los Angeles, Cancer, LAVS, UCLA, laboratory, lab products, 2016

UCLA Life Science: Biochemists Convert Glucose Without the Help of Cells

Posted by Laura Braden on Mon, Jul 11, 2016

Beta-D-glucose-2D-skeletal-hexagon.png

A team of biochemists at UCLA have created a novel system of converting glucose into highly useful chemical compounds, such as those needed to create biofuels and pharmaceuticals. Previous research endeavors relied on using cells to convert sugar into desired compounds. This has been difficult to achieve because cells would rather use sugar for their own natural uses, such as building proteins and cell walls. The UCLA biochemists have recently developed a way to achieve the conversion of glucose into desired compounds- without using cells.

Read More

Tags: CA, University of California Los Angeles, Los Angeles, Biochemistry, chemistry research, Chemistry, LAVS, UCLA, Biotechnology Vendor Showcase, 2016, Western, glucose

UCLA Receives $7.6M for Research on Tumor Eradicating Stem Cells

Posted by Katheryn Rein on Wed, Apr 06, 2016

A UCLA cancer research team has recently received a $7.6 million grant from the California Institute for Regenerative Medicine. This award will support research into genetically engineered white blood cells which can selectively target and kill tumor cells, while simultaneously activating other immune cells to do the same.

Read More

Tags: CA, University of California Los Angeles, Stem Cells, Los Angeles, genetic engineering, UCLA, Biotechnology Vendor Showcase, new funding, cancer research funding, tumor cells

New Translational Genomics Department Established at USC

Posted by Laura Braden on Wed, Mar 09, 2016

The University of Southern California in Los AngelesThe University of Southern California is known around the world as being a leader in many fields, including life science research, and even has a separate campus dedicated to teaching and researching health sciences. With 6 basic science departments, 18 clinical departments, 7 research institutes, and dozens of research centers and programs, the Keck School of Medicine on the USC Health Science Campus is continuing to expand and increase life science capabilities. In 2015, the university opened a new $15 million Center for Pullmonary Research as well as a new $10 million Center for Convergent Bioscience.

The ever-growing campus is adding a new department to its impressive list, with the recent establishment of a Translational Genomics Department to be located in the Harlyne J. Norris Research Tower on the USC Health Sciences campus.

Read More

Tags: CA, University of Southern California, Southwest, USC, Los Angeles, BRPF, 2016, BioResearch Product Faire, Translational Genomics

UCLA Receives $1M Donation for Lung Disease Treatments

Posted by Laura Braden on Mon, Jan 25, 2016

UCLA has received $1 million dollars to support research into lung disease and organ rejection. When vital organs in the body, such as the lungs, begin to fail, an organ transplant can be a solution to the problem. However, receiving a transplant may have its own complications, such as the body rejecting its new organ.

Now, thanks to a generous donation of $1 million dollars from Michael and Linda Keston, researchers from the Division of Pulmonary and Critical Care Medicine at the UCLA David Geffen School of Medicine will be able to continue studying lung disease and the organ rejection commonly following a transplant. 

Read More

Tags: CA, University of California Los Angeles, Los Angeles, LAVS, UCLA, Biotechnology Vendor Showcase, new funding, 2016, Lung Disease, organ transplant, organ rejection

UCLA receives $4.2M from NIH to Study Placental Development

Posted by Robert Larkin on Tue, Nov 24, 2015

pregnant-1435168During pregnancy, much of a fetus’ development is contingent on the condition and function of the placenta. It is responsible for the transmission of substances from mother to child that are critical to early development, including blood, oxygen and nutrients, without which the fetus could not exist. Sometimes, however, environmental effects can cause deficiencies in the placenta, which can lead to harmful side effects such as preterm birth or even death.

Read More

Tags: CA, University of California Los Angeles, Medical Research, California, Los Angeles, Development, UCLA, Biotechnology Vendor Showcase, NIH funding, NIH award, Southwest Region, 2016, best science tradeshows, pollution, pregnancy

UCLA Researchers I.D. Tumor-Fueling Mechanism

Posted by Robert Larkin on Tue, Aug 04, 2015

fuel, cancer research, ucla, biotechLike any living organism, cancer cells rely on fuel in order to survive and grow. Unfortunately for many, the growth of cancer cells is extremely deleterious to human health. That is why a major facet of cancer research currently involves locating and preventing the mechanism for fueling cancer cells.

Read More

Tags: CA, University of California Los Angeles, cancer research, California, Los Angeles, Cancer Treatment, 2015, LAVS, UCLA, Research Funding, Life Science, Biotechnology Vendor Showcase, Southwest Region, Prostate cancer

Subscribe to Company News